{
  "ticker": "LLY",
  "target_date": "2025-06-25",
  "actual_date": "2025-06-25",
  "collected_at": "2025-12-08T11:56:13.192134",
  "price": {
    "open": 776.15,
    "high": 796.03,
    "low": 770.77,
    "close": 789.4042358398438,
    "volume": 3023100,
    "change_1d_pct": 1.83,
    "change_7d_pct": -3.3,
    "change_30d_pct": 5.08
  },
  "technicals": {
    "rsi_14": 59.45,
    "sma_20": 771.54,
    "sma_50": 776.81,
    "macd": 5.609,
    "macd_signal": 5.321,
    "macd_histogram": 0.289,
    "bb_upper": 829.72,
    "bb_lower": 713.36,
    "price_vs_sma20_pct": 2.32,
    "price_vs_sma50_pct": 1.62,
    "volume_ratio": 0.92
  },
  "fundamentals": {
    "market_cap": 892350955520,
    "pe_ratio": 48.77119,
    "forward_pe": 43.92851,
    "price_to_book": 37.47816,
    "price_to_sales": 15.017737,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.48,
    "pct_from_52w_low": 59.58
  },
  "macro": {
    "spy": {
      "price": 605.44,
      "change_1d_pct": 0.06,
      "change_7d_pct": 1.03
    },
    "vix": {
      "level": 16.76,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.29
    },
    "dollar_index": {
      "level": 97.68
    },
    "gold": {
      "price": 3327.1
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Buy Eli Lilly While The Market Hesitates And Let Time Make You Dominate",
      "source": "SeekingAlpha",
      "datetime": 1750892889,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b633842c952421d9de1ca80e5eaecb30ab84127e58c327e6ec01e3d702687c2b"
    },
    {
      "headline": "Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity",
      "source": "Yahoo",
      "datetime": 1750874860,
      "summary": "Viking Therapeutics stock remains under pressure, but analysts said Wednesday the company's strategy for its Phase 3 studies could pay off.",
      "url": "https://finnhub.io/api/news?id=054f12b359d010b4310d08ea300d2446f9ca2c144f2ff37d6623230817623850"
    },
    {
      "headline": "Eli Lilly and Company (LLY) Is Going To Be A \u201cTrillion-Dollar Market Cap,\u201d Says Jim Cramer",
      "source": "Yahoo",
      "datetime": 1750868439,
      "summary": "Eli Lilly and Company (NYSE:LLY) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 Stocks. Eli Lilly and Company (NYSE:LLY) is one of the most frequently discussed stocks on Cramer\u2019s morning show. He is a fan of the firm not only due to its lead in the [\u2026]",
      "url": "https://finnhub.io/api/news?id=ca51a49ea085efe1d6b114d98a449985a1df69b5a8b2142c166d637390198fde"
    },
    {
      "headline": "Novo Nordisk A/S (NVO): \u201cHow Could They Be So Far Behind?,\u201d Wonders Jim Cramer",
      "source": "Yahoo",
      "datetime": 1750868407,
      "summary": "Novo Nordisk A/S (NYSE:NVO) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 Stocks. Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical giant that is a key player in the weight loss drug market. The firm\u2019s shares have lost 15.7% year-to-date. Novo Nordisk ",
      "url": "https://finnhub.io/api/news?id=d28fa12025d5503c909cf2a8b33d344ec156775afd6dbe55ad860bcaa798bee8"
    },
    {
      "headline": "NKTR Stock Soars as Lead Drug Meets Goal in Atopic Dermatitis Study",
      "source": "Yahoo",
      "datetime": 1750865400,
      "summary": "Nektar's lead candidate, rezpeg, hits key targets in a phase IIb eczema study, sending shares soaring 156.3% on Tuesday.",
      "url": "https://finnhub.io/api/news?id=c00813a70079ca6515480ec697b280cf9da913dba5a62c1cdbb0293b8cb70284"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750199300.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000176/xslF345X05/wk-form4_1750199300.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750199159.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000174/xslF345X05/wk-form4_1750199159.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198988.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000172/xslF345X05/wk-form4_1750198988.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198711.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000170/xslF345X05/wk-form4_1750198711.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198504.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000168/xslF345X05/wk-form4_1750198504.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}